AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
TUMOR-THERAPY WITH RADIOLABELED ANTIBODIES - OPTIMIZATION OF THERAPY
Authors: VRIESENDORP HM QUADRI SM BORCHARDT PE
Citation: Hm. Vriesendorp et al., TUMOR-THERAPY WITH RADIOLABELED ANTIBODIES - OPTIMIZATION OF THERAPY, Biodrugs, 10(4), 1998, pp. 275-293
MULTIMODALITY RADIOLABELED IMMUNOGLOBULIN THERAPY (RIT)
Authors: VRIESENDORP HM
Citation: Hm. Vriesendorp, MULTIMODALITY RADIOLABELED IMMUNOGLOBULIN THERAPY (RIT), CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 23-23
INTRACOMPARTMENTAL ADMINISTRATION OF RADIOLABELED HUMAN-IGM
Authors: BORCHARDT PE VRIESENDORP HM FREEDMAN RS QUADRI SM
Citation: Pe. Borchardt et al., INTRACOMPARTMENTAL ADMINISTRATION OF RADIOLABELED HUMAN-IGM, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 24-24
THE NEXT (3RD) DIMENSION TO DOSING OF ANTICANCER AGENTS
Authors: VRIESENDORP HM
Citation: Hm. Vriesendorp, THE NEXT (3RD) DIMENSION TO DOSING OF ANTICANCER AGENTS, Journal of clinical oncology, 16(11), 1998, pp. 3715-3716
INDIUM-111-LABELED AND YTTRIUM-90-LABELED HUMAN MONOCLONAL IMMUNOGLOBULIN-M TARGETING OF HUMAN OVARIAN-CANCER IN MICE
Authors: BORCHARDT PE QUADRI SM FREEDMAN RS VRIESENDORP HM
Citation: Pe. Borchardt et al., INDIUM-111-LABELED AND YTTRIUM-90-LABELED HUMAN MONOCLONAL IMMUNOGLOBULIN-M TARGETING OF HUMAN OVARIAN-CANCER IN MICE, The Journal of nuclear medicine, 39(3), 1998, pp. 476-484
INTRALESIONAL RADIOLABELED HUMAN MONOCLONAL IGM IN HUMAN TUMOR XENOGRAFTS
Authors: BORCHARDT PE QUADRI SM FREEDMAN RS VRIESENDORP HM
Citation: Pe. Borchardt et al., INTRALESIONAL RADIOLABELED HUMAN MONOCLONAL IGM IN HUMAN TUMOR XENOGRAFTS, Radiotherapy and oncology, 44(3), 1997, pp. 283-293
PRECLINICAL ANALYSIS OF RADIOLABELED ANTI-GD2 IMMUNOGLOBULIN-G
Authors: VRIESENDORP FJ QUADRI SM FLYNN RE MALONE MR CROMEENS DM STEPHENS LC VRIESENDORP HM
Citation: Fj. Vriesendorp et al., PRECLINICAL ANALYSIS OF RADIOLABELED ANTI-GD2 IMMUNOGLOBULIN-G, Cancer, 80(12), 1997, pp. 2642-2649
RECURRENCE OF HODGKINS-DISEASE AFTER IN-111 AND Y-90 LABELED ANTIFERRITIN ADMINISTRATION
Authors: VRIESENDORP HM QUADRI SM ANDERSSON BS WYLLIE CT DICKE KA
Citation: Hm. Vriesendorp et al., RECURRENCE OF HODGKINS-DISEASE AFTER IN-111 AND Y-90 LABELED ANTIFERRITIN ADMINISTRATION, Cancer, 80(12), 1997, pp. 2721-2727
ALLOGENEIC BLOOD OR MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - TIMING OF TRANSPLANTATION AND POTENTIAL EFFECT OF FLUDARABINEON ACUTE GRAFT-VERSUS-HOST DISEASE
Authors: KHOURI IF PRZEPIORKA D VANBESIEN K OBRIEN S PALMER JL LERNER S MEHRA RC VRIESENDORP HM ANDERSSON BS GIRALT S KORBLING M KEATING MJ CHAMPLIN RE
Citation: If. Khouri et al., ALLOGENEIC BLOOD OR MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - TIMING OF TRANSPLANTATION AND POTENTIAL EFFECT OF FLUDARABINEON ACUTE GRAFT-VERSUS-HOST DISEASE, British Journal of Haematology, 97(2), 1997, pp. 466-473
HEMATOLOGIC SIDE-EFFECTS OF RADIOLABELED IMMUNOGLOBULIN THERAPY
Authors: VRIESENDORP HM QUADRI SM ANDERSSON BS DICKE KA
Citation: Hm. Vriesendorp et al., HEMATOLOGIC SIDE-EFFECTS OF RADIOLABELED IMMUNOGLOBULIN THERAPY, Experimental hematology, 24(10), 1996, pp. 1183-1190
PROPOSAL FOR TRANSLATIONAL ANALYSIS AND DEVELOPMENT OF CLINICAL RADIOLABELED IMMUNOGLOBULIN THERAPY
Authors: VRIESENDORP HM QUADRI SM JAECKLE KA FREEDMAN RS CROMEENS DM
Citation: Hm. Vriesendorp et al., PROPOSAL FOR TRANSLATIONAL ANALYSIS AND DEVELOPMENT OF CLINICAL RADIOLABELED IMMUNOGLOBULIN THERAPY, Radiotherapy and oncology, 41(2), 1996, pp. 151-161
INTRAPERITONEAL INDIUM-111-LABELED AND YTTRIUM-90-LABELED HUMAN-IGM (AC6C3-2B12) IN NUDE-MICE BEARING PERITONEAL CARCINOMATOSIS
Authors: QUADRI SM MALIK AB CHU HB FREEDMAN RS VRIESENDORP HM
Citation: Sm. Quadri et al., INTRAPERITONEAL INDIUM-111-LABELED AND YTTRIUM-90-LABELED HUMAN-IGM (AC6C3-2B12) IN NUDE-MICE BEARING PERITONEAL CARCINOMATOSIS, The Journal of nuclear medicine, 37(9), 1996, pp. 1545-1551
BIODISTRIBUTION AND TUMOR-LOCALIZATION OF IN-111-LABELED UNMODIFIED AND MODIFIED F(AB')(2) FRAGMENTS OF HUMAN MONOCLONAL IGM-(16.88) IN A NUDE-MOUSE MODEL
Authors: QUADRI SM SIDDIQUI A KLEIN JL VRIESENDORP HM
Citation: Sm. Quadri et al., BIODISTRIBUTION AND TUMOR-LOCALIZATION OF IN-111-LABELED UNMODIFIED AND MODIFIED F(AB')(2) FRAGMENTS OF HUMAN MONOCLONAL IGM-(16.88) IN A NUDE-MOUSE MODEL, Nuclear medicine and biology, 22(4), 1995, pp. 413-423
TUMOR TARGETING AND PHARMACOKINETICS OF UNMODIFIED AND MODIFIED F(AB)(2) FRAGMENTS OF AN ANTI-CEA MURINE MONOCLONAL-ANTIBODY (IMMU-14)
Authors: SIDDIQUI A QUADRI SM GRIFFITHS GL GOLDENBERG DM VRIESENDORP HM
Citation: A. Siddiqui et al., TUMOR TARGETING AND PHARMACOKINETICS OF UNMODIFIED AND MODIFIED F(AB)(2) FRAGMENTS OF AN ANTI-CEA MURINE MONOCLONAL-ANTIBODY (IMMU-14), Nuclear medicine and biology, 22(4), 1995, pp. 425-435
SURVIVAL OF PATIENTS WITH RESISTANT HODGKINS-DISEASE AFTER POLYCLONALYTTRIUM 90-LABELED ANTIFERRITIN TREATMENT
Authors: HERPST JM KLEIN JL LEICHNER PK QUADRI SM VRIESENDORP HM
Citation: Jm. Herpst et al., SURVIVAL OF PATIENTS WITH RESISTANT HODGKINS-DISEASE AFTER POLYCLONALYTTRIUM 90-LABELED ANTIFERRITIN TREATMENT, Journal of clinical oncology, 13(9), 1995, pp. 2394-2400
LIVER TOXICITY INDUCED BY COMBINED EXTERNAL-BEAM IRRADIATION AND RADIOIMMUNOGLOBULIN THERAPY
Authors: WANG S QUADRI SM TANG XZ STEPHENS LC LOLLO CP BARTHOLOMEW RM VRIESENDORP HM
Citation: S. Wang et al., LIVER TOXICITY INDUCED BY COMBINED EXTERNAL-BEAM IRRADIATION AND RADIOIMMUNOGLOBULIN THERAPY, Radiation research, 141(3), 1995, pp. 294-302
PRECLINICAL ANALYSIS OF INTRAPERITONEAL ADMINISTRATION OF IN-111-LABELED HUMAN TUMOR REACTIVE MONOCLONAL IGM AC6C3-2B12
Authors: QUADRI SM MALIK AB TANG XZ PATENIA R FREEDMAN RS VRIESENDORP HM
Citation: Sm. Quadri et al., PRECLINICAL ANALYSIS OF INTRAPERITONEAL ADMINISTRATION OF IN-111-LABELED HUMAN TUMOR REACTIVE MONOCLONAL IGM AC6C3-2B12, Cancer research, 55(23), 1995, pp. 5736-5742
REVIEW OF 5 CONSECUTIVE STUDIES OF RADIOLABELED IMMUNOGLOBULIN THERAPY IN HODGKINS-DISEASE
Authors: VRIESENDORP HM MORTON JD QUADRI SM
Citation: Hm. Vriesendorp et al., REVIEW OF 5 CONSECUTIVE STUDIES OF RADIOLABELED IMMUNOGLOBULIN THERAPY IN HODGKINS-DISEASE, Cancer research, 55(23), 1995, pp. 5888-5892
ETOPOSIDE, CYCLOPHOSPHAMIDE, TOTAL-BODY IRRADIATION, AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES
Authors: GIRALT SA LEMAISTRE CF VRIESENDORP HM ANDERSSON BS DIMOPOULOS M GAJEWSKI J VANBESIEN K MEHRA R PRZEPIORKA D KHOURI I YAU J KANTARJIAN H DEISSEROTH AB CHAMPLIN RE
Citation: Sa. Giralt et al., ETOPOSIDE, CYCLOPHOSPHAMIDE, TOTAL-BODY IRRADIATION, AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES, Journal of clinical oncology, 12(9), 1994, pp. 1923-1930
AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - PRELIMINARY-RESULTS
Authors: KHOURI IF KEATING MJ VRIESENDORP HM READING CL PRZEPIORKA D HUH YO ANDERSSON BS VANBESIEN KW MEHRA RC GIRALT SA IPPOLITI C MARSHALL M THOMAS MW OBRIEN S ROBERTSON LE DEISSEROTH AB CHAMPLIN RE
Citation: If. Khouri et al., AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - PRELIMINARY-RESULTS, Journal of clinical oncology, 12(4), 1994, pp. 748-758
RADIOLABELED IMMUNOGLOBULIN THERAPY FOR HODGKINS-DISEASE - NO MAGIC, NO BULLET
Authors: VRIESENDORP HM QUADRI SM
Citation: Hm. Vriesendorp et Sm. Quadri, RADIOLABELED IMMUNOGLOBULIN THERAPY FOR HODGKINS-DISEASE - NO MAGIC, NO BULLET, Experimental hematology, 22(8), 1994, pp. 732-732
RADIOBIOLOGY OF TOTAL-BODY RADIATION
Authors: VRIESENDORP HM CHU H OCHRAN TG BESA PC CHAMPLIN RE
Citation: Hm. Vriesendorp et al., RADIOBIOLOGY OF TOTAL-BODY RADIATION, Bone marrow transplantation, 14, 1994, pp. 4-8
INTERLEUKIN-2 FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER HAPLOIDENTICAL MARROW TRANSPLANTATION
Authors: PRZEPIORKA D IPPOLITI C KOBERDA J CHAN KW KHOURI IF FISCHER HE HUH YO ESCUDIER SM SEONG D DAVIS M GAJEWSKI J VRIESENDORP HM CHAMPLIN RE
Citation: D. Przepiorka et al., INTERLEUKIN-2 FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER HAPLOIDENTICAL MARROW TRANSPLANTATION, Transplantation, 58(7), 1994, pp. 858-860
SEPARATION OF CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) CELLS BY A DISCONTINUOUS DENSITY GRADIENT - CORRELATION WITH CLINICAL STAGE
Authors: GORDON LI SHAPIRO GI ROSEN ST KIES MS PRACHAND S VRIESENDORP HM
Citation: Li. Gordon et al., SEPARATION OF CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) CELLS BY A DISCONTINUOUS DENSITY GRADIENT - CORRELATION WITH CLINICAL STAGE, International journal of oncology, 2(6), 1993, pp. 981-984
PRECLINICAL EVALUATION OF INTRAVENOUSLY ADMINISTERED IN-111 LABELED AND Y-90 LABELED B72.3 IMMUNOCONJUGATE (GYK-DTPA) IN BEAGLE DOGS
Authors: QUADRI SM SHAO Y BLUM JE LEICHNER PK WILLIAMS JR VRIESENDORP HM
Citation: Sm. Quadri et al., PRECLINICAL EVALUATION OF INTRAVENOUSLY ADMINISTERED IN-111 LABELED AND Y-90 LABELED B72.3 IMMUNOCONJUGATE (GYK-DTPA) IN BEAGLE DOGS, Nuclear medicine and biology, 20(5), 1993, pp. 559-570
Risultati: 1-25 | 26-29